
Medical Marijuana, Inc.
OTC:MJNA
0.0051 (USD) • At close November 17, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2010 | 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 14.907 | 16.811 | 25.099 | 34.123 | 46.937 | 75.56 | 59.825 | 26.523 | 8.004 | 9.215 | 14.523 | 5.06 | 5.194 | 0.06 | 0.013 |
Cost of Revenue
| 3.246 | 5.566 | 6.64 | 7.26 | 9.211 | 17.829 | 19.486 | 8.114 | 3.366 | 3.911 | 7.496 | 2.12 | 1.266 | 0.008 | 0 |
Gross Profit
| 11.66 | 11.245 | 18.459 | 26.863 | 37.726 | 57.731 | 40.34 | 18.409 | 4.638 | 5.305 | 7.027 | 2.94 | 3.928 | 0.053 | 0.013 |
Gross Profit Ratio
| 0.782 | 0.669 | 0.735 | 0.787 | 0.804 | 0.764 | 0.674 | 0.694 | 0.579 | 0.576 | 0.484 | 0.581 | 0.756 | 0.876 | 0.992 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0.077 | 0.431 | 0.08 | 0 | 0 | 0 | 0 | 0.018 | 0 | 0 | 0 |
General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 12.737 | 14.477 | 15.085 | 7.827 | 7.812 | 6.884 | 3.628 | 0.615 | 2.429 | 0.182 |
Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 41.265 | 33.88 | 1.606 | 0.646 | 0.458 | 1.472 | 0.237 | 0.059 | 0.004 | 0.008 |
SG&A
| 11.661 | 14.896 | 23.161 | 28.64 | 39.801 | 55.879 | 49.801 | 16.691 | 8.473 | 8.271 | 8.356 | 3.865 | 0.674 | 2.433 | 0.19 |
Other Expenses
| 0 | -0.84 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.408 | -1.47 | 0 | 0 | 0 | 0 |
Operating Expenses
| 11.661 | 15.736 | 23.161 | 28.64 | 39.878 | 56.31 | 49.881 | 23.145 | 9.038 | 8.953 | 9.625 | 3.937 | 0.674 | 2.433 | 0.19 |
Operating Income
| -0.001 | -4.491 | -4.702 | -1.776 | -2.152 | 1.421 | -9.542 | -3.965 | -4.397 | -4.325 | -2.604 | 0.211 | 3.253 | -2.38 | -0.178 |
Operating Income Ratio
| -0 | -0.267 | -0.187 | -0.052 | -0.046 | 0.019 | -0.159 | -0.149 | -0.549 | -0.469 | -0.179 | 0.042 | 0.626 | -39.374 | -13.702 |
Total Other Income Expenses Net
| -0.64 | -0.592 | -10.647 | -2.994 | -93.627 | 82.983 | -193.392 | -137.462 | -22.505 | -99.591 | -1.927 | -1.256 | -0.02 | 2.38 | 0 |
Income Before Tax
| -0.642 | -5.084 | -15.349 | -4.771 | -95.779 | 84.404 | -202.934 | -142.198 | -26.356 | -103.239 | -4.531 | -0.997 | 3.234 | 0 | 0 |
Income Before Tax Ratio
| -0.043 | -0.302 | -0.612 | -0.14 | -2.041 | 1.117 | -3.392 | -5.361 | -3.293 | -11.203 | -0.312 | -0.197 | 0.623 | 0 | 0 |
Income Tax Expense
| 0 | -0 | -0 | 0 | -0 | -0 | 0 | 12.925 | 10.665 | -127.57 | -0.521 | -24.42 | 0.02 | 2.38 | 0 |
Net Income
| -0.642 | -5.084 | -15.349 | -4.771 | -95.779 | 84.404 | -202.934 | -148.105 | -25.908 | 25.971 | -4.488 | 24.611 | 3.234 | -2.38 | -0.178 |
Net Income Ratio
| -0.043 | -0.302 | -0.612 | -0.14 | -2.041 | 1.117 | -3.392 | -5.584 | -3.237 | 2.818 | -0.309 | 4.864 | 0.623 | -39.381 | -13.702 |
EPS
| -0 | -0.001 | -0.004 | -0.001 | -0.03 | 0.034 | -0.094 | -0.045 | -0.008 | 0.009 | -0.003 | 0.026 | 0.004 | -0.005 | -0.001 |
EPS Diluted
| -0 | -0.001 | -0.004 | -0.001 | -0.03 | 0.034 | -0.094 | -0.045 | -0.008 | 0.009 | -0.003 | 0.026 | 0.004 | -0.005 | -0.001 |
EBITDA
| -0.074 | -4.719 | -14.944 | -4.04 | -95.032 | 1.115 | -9.417 | -134.685 | -14.23 | -3.642 | -2.485 | -0.997 | 3.254 | -2.38 | -0.177 |
EBITDA Ratio
| -0.005 | -0.281 | -0.595 | -0.118 | -2.025 | 0.015 | -0.157 | -5.078 | -1.778 | -0.395 | -0.171 | -0.197 | 0.627 | -39.374 | -13.674 |